Tweenvest Stocks

Shandong Boan Biotechnology Co., Ltd. (SEHK: 6955)

Health Care · Biotechnology · CN

HK$3.10

+2.31% today · -73.3% 1Y

Shandong Boan Biotechnology Co., Ltd. (SEHK: 6955) operates in the Biotechnology industry within the Health Care sector. The company is valued at $245.84M and employs 690 people.

Over the last twelve months the share price has lost 73.3%, trading between 2.40 and 12.66.

Tweenvest scores Shandong Boan Biotechnology Co., Ltd. across four factors: quality 57/100, value 65/100. Its strongest factor is value.

6955 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$245.84M
Revenue (TTM)
$91.92M
P/E
—
EPS
-0.16
Dividend yield
—
Beta (5Y)
0.15
52-week high
HK$12.66
52-week low
HK$2.40
Avg volume (3M)
—
Shares outstanding
622.33M
Employees
690
Next earnings
—

About Shandong Boan Biotechnology Co., Ltd.

Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.

ISIN
CNE100005RV4
Founded
2013
Listed since
Dec 29, 2022
Exchange
The Stock Exchange of Hong Kong Ltd.
Currency
HKD
CompanyMarket capPriceDay
HighTide Therapeutics, Inc.SEHK: 2511$249.35MHK$3.43-2.14%
AC Immune SANasdaqGM: ACIU$248.57M$2.50-8.26%
Racura Oncology LtdASX: RAC$248.34MAU$1.82-5.47%
Q32 Bio Inc.NasdaqCM: QTTB$248.28M$8.34+1.34%
Acepodia, Inc.TPEX: 6976$244.38MNT$13.40+4.69%
Oryzon Genomics S.A.BME: ORY$243.20M€2.65+0.76%
Polaris GroupTWSE: 6550$242.78MNT$16.70-0.30%
Greenwich LifeSciences, Inc.NasdaqCM: GLSI$242.63M$16.53-2.65%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.